African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent

PLoS Medicine

Volumn 5, Issue 12, 2008, Pages 1653-1657

  Kaleebu, Pontiano ^a   Ablmiku, Alash'le ^b   El Halabi, Shenaaz ^c   Koulla Shiro, Sinata ^d   Mamotte, Nicole ^e   Mboup, Souleymane ^f   Mugerwa, Roy ^g   Nkengasong, John ^h   Toure Kane, Coumba ^f   Tucker, Tim ⁱ   Wassenaar, Douglas ^e   Williamson, Carolyn ^j   Wolday, Dawit ^k  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

^c Health Research Unit   (Botswana)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

^f Laboratoire de Bacteriologie Virologie   (Senegal)

^g MAKERERE UNIVERSITY   (Uganda)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ Scientific Medical Research (Proprietary) Ltd   (South Africa)

^j UNIVERSITY OF CAPE TOWN   (South Africa)

^k Medical Biotech Laboratory   (Ethiopia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; DISEASE CONTROL; DISEASE TRANSMISSION; DRUG DEVELOPMENT; ETHICS; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN RIGHTS; INTERPERSONAL COMMUNICATION; LAW; MEDICAL RESEARCH; PUBLIC HEALTH PROBLEM; VACCINATION; BIOLOGICAL MODEL; COOPERATION; DRUG DESIGN; HEALTH PROMOTION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LEGAL ASPECT; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH; SYNTHESIS; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; AIDS VACCINES; BIOMEDICAL RESEARCH; COOPERATIVE BEHAVIOR; DRUG DESIGN; EFFICIENCY, ORGANIZATIONAL; HEALTH PROMOTION; HIV-1; HUMAN RIGHTS; HUMANS; MODELS, BIOLOGICAL; NATIONAL HEALTH PROGRAMS; WORLD HEALTH ORGANIZATION;

EID: 58149476464     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0050236     Document Type: Article

References (13)

1. Gottlieb MS, Schtoff R, Schtankei HM, Weissman JD, Fan PT, et al. (1981) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. N Engl J Med 305:1425-1431.
2. UNAIDS/WHO (2007) 2007 AIDS epidemic update. Available: http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2007/ default.asp.Accessed 6 November 2008.
3. Dionisio D, Cao Y, Hongzhou L, Kraisintu K, Messeri D (2006) Affordable antiretroviral drugs for the under-served markets: How to expand equitable access against the backdrop of challenging scenarios? Curr HIV Respondent 4: 3-20.
4. UNICEF/UNAIDS/WHO (2007) Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector. Available: http://www.who.int/hiv/ mediacentre/universal-access-progress-report-en.pdf. Accessed 29 October 2008.
5. WHO (2000) The Nairobi Declaration: An African appeal for an AIDS vaccine. Available: http://www.who.int/vaccine-research/diseases/hiv/en/JC469- NairobiDeclar-E.pdf. Accessed 29 October 2008.
6. Vogel G (2004) AIDS vaccines. G8 leaders endorse global effort. Science 304: 1728.
7. WHO/UNAIDS/AAVP International Expert Group, Osmanov S (2007) Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana. Aids 21: W1-W10.
8. Milford C, Wassenaar D, Slack C (2006) Resources and need of research ethics committees in Africa: Preparations for HIV vaccine trials. IRB 28: 1-9.
9. Wassenaar DR, Barsdorf NW (2007) The ethical involvement of women in HIV vaccine trials in Africa: Discussion paper developed for the African AIDS Vaccine Programme. Women Health 45: 37-50.
10. Andanda P (2008) Human-tissue related inventions: Ownership and intellectual property rights in international collaborative research in developed for the African AIDS Vaccine Programme. J Med Ethics 34: 171-179.
11. Ndembi N, Lyagoba F, Nanteza B, Kushemererwa G, Serwanga J. et al. (2008) Antiretroviral drug resistance surveillance among newly HIV-1 diagnosed women attending antenatal clinic in Entebbe, Uganda. AIDS Respondent Hum Retroviruses 24: 889-895.
12. Mugerwa RD, Kaleebu P, Mugyenyi P, Katongole-Mbidde E, Hom DL, et al. (2002) First trial of the HIV-1 vaccine in Africa: Ugandan experience. BMJ 324: 226-229.
13. Kalusner RD, Fauci AS, Corey L, Nabel GJ, Gayle, H, et al. (2003). The need for a global HIV vaccine enterprise. Science 300: 2036-2039.